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Introduction 
Infection of extra-anatomic vascular prosthesis in the 
aortofemoral area is reported episodically in the lit- 
erature so that its frequency is still uncertain, though 
in axillopopliteal grafts it was found to be 3.6%. 1 It is 
considered to be a benign disease with a good pos- 
sibility of conservative treatment or segmental re- 
section. 2 In our experience over 15 years we had the 
impression that this was not always so, and that 
differences existed in incidence, severity, evolution, 
ways of treatment and final outcome between cases 
operated upon for obstructive arterial disease and 
those treated by extra-anatomic bypass for the man- 
agement of an infected aortic graft. Therefore we 
studied retrospectively a series of 213 consecutive 
patients in whom 225 grafts were implanted, analysing 
indications, treatment and outcome. 
Patients and Methods 
From November 1977 to June 1995, 213 patients were 
submitted to 225 extra-anatomic procedures for aorto- 
femoral disease. Their age range was 52-84, with 146 
men and 67 women. Diabetes was present in 29%, 
hypertension i 47% and smoking in 32%. Indications 
for extra-anatomic arterial repair were: poor general 
condition in 154 (72.3%), poor runoff in patients other- 
wise in good or reasonable general conditions in 43 
(20.2%) and local conditions in 16 (7.5%). Local con- 
ditions were extreme obesity in one patient, multiple 
previous abdominal surgery in one, large and severe 
scarring in the groin from previous surgery in two, 
widespread cancer of the bladder with post-radiation 
sclerosis in one and infection of an aortic graft in 11. 
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Al l  the patients operated upon for reasons other than 
aortic graft infection had chronic arterial obstructive 
disease with rest pain and/or  trophic changes (Fon- 
taine 3rd and 4th stage). Acute cases are not included 
in this report. 
The procedures and graft materials were as reported 
in Table 1. A vein graft was often used for a cross- 
femoral bypass but in a few cases also for an axillo- 
femoral bypass. Most of the composite grafts had an 
ePTFE or Dacron portion in the axillofemoral position 
and an additional segment of vein as a cross-femoral 
branch. In patients treated for an infected aortic graft 
axil lofemoral/popliteal bypasses were carried out 
using only ePTFE (10) or dacron (one) grafts. Early 
and late extra-anatomic graft infection was generally 
and promptly identified on a clinical basis; however, 
Gram stain and culturing studies were applied in all 
cases and labelled leukocyte scintigraphy was carried 
out in four. 
For all grafts which were patent on discharge, fol- 
low-up included clinical assessment and non-invasive 
investigations at 1 month, 3 months and every 6 
months thereafter. When problems arose or were sus- 
pected through ultrasound investigation, angiography 
was advised. Four failing and 11 occluded grafts were 
Table 1. Extra-anatomic procedures and graft material in the aorto- 
femoral area: 225 grafts in 213 patients. 
No. % 
Axillobifemoral 159 70.7 
Cross-femoral 56 25.0 
Axillopopliteal 8 3.5 
Obturator 2 0.8 
ePTFE 79 35. ]
Composite* 67 29.8 
Autogenous vein 56 24.9 
Dacron 14 6.2 
Homologous vein 9 4.0 
* Most of the composite grafts were done by ePTFE or Dacron in 
axillofemoral position and a segment of vein as a cross-femoral. 
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Table 2. Early and late infection in 225 grafts in the aortofemoral 
area related to extra-anatomic procedure and graft material. 
n % 
Early infection 7/225 3.1 
Late infection 1 / 187 0.5 
Overall 8/225 3.6 
Axillofemoral/popliteal gr ft infection 8 
ePTFE 7/79 8.8 
Dacron 1/14 7.1 
No infection was detected in composite, autogenous or homologous 
vein grafts. 
treated by endovascular techniques, urgery or com- 
bined procedures. 
Results 
Early results show a mortality of 2.8% (six patients) 
and an occlusion rate of 9.8% (22 grafts). One de- 
tachment from the axillary artery was not due to 
infection and was promptly repaired. Early infection 
affected seven out of 225 grafts (3.1%). Late results 
were available in 176 patients (187 grafts) with a 
follow-up from 6 months to 15 years (a mean of 
5 years). Mortality was 45% due mainly to cardiac 
problems, but also to cancer and respiratory diseases. 
Patency was 66%. Four pseudoaneurysms were not 
due to infection and were successfully repaired. One 
embolism of the upper limb was observed and cor- 
rected by transbrachial embolectomy in a patient with 
an occluded axillofemoral graft which was removed 
while the axillary was patch-repaired. Late infection 
was detected in only one case (0.5%). 
Summarising the results as far as extra-anatomic 
grafts infection is concerned (Table 2) there was an 
overall incidence of infection of 8/225 grafts (3.6%.) 
All infected grafts were axillofemoral or axillopopliteal 
and all of them were ePTFE or Dacron, with an in- 
cidence of infection of 8.8% and 7.1%, respectively. No 
infection was detected in composite, autogenous or 
homologous vein grafts. Five of the early infections 
occurred in four patients who had an infected aorto- 
femoral graft. Three had total graft infection with 
Pseudomonas aeruginosa in two and a highly virulent 
strain of candida in 1. One of these was treated by a 
Dacron axillopopliteal bypass in a one-stage pro- 
cedure, including total removal of the previous aorto- 
femoral bypass. The new graft became rapidly infected, 
and was removed and followed by major amputation 
and death. The other two patients had one unilateral 
and one bilateral axillofemoral/popliteal bypass as the 
first step of a staged procedure but although the 
abdominal graft was removed, their extra-anatomic 
grafts became infected, bled, had to be totally excised, 
and major amputation followed. One patient had an 
isolated groin infection of an aortobifemoral bypass 
(Staphylococcus epidermidis). The involved limb of the 
graft was removed and an ePTFE axilloprofunda fem- 
oris bypass lateral to the infected groin area was carried 
out. The distal part of this graft also became infected. 
A brief period of conservative treatment was tried, 
but lack of improvement required partial excision of 
the new graft and the completion of an axillopopliteal 
bypass plus a short jump bypass to the posterior tibial. 
The outcome was favourable and infection has not 
resurfaced almost 3 years later. The other two early 
infections occurred in two patients having ePTFE ax- 
illofemoral bypasses for chronic occlusive arterial dis- 
ease. In one case Staphylococcus aureus was responsible 
for a proximal infection leading to anastomotic dis- 
ruption. The axillary artery could not be saved and 
revascularisation f the upper limb was performed 
using a homologous vein subclavian-brachial bypass. 
Although the axillofemoral graft was totally excised, 
the lower limb remained reasonably viable and pain- 
less with the support of a spinal cord stimulation. 
The other patient had a mid-portion infection of an 
axillofemoral graft due to wound infection. Cultures 
were negative and only white blood cells were seen 
on Gram's stain. 
Conservative treatment was used successfully. The 
wound and graft healed with no recurrence for 16 
months when the patient died of a heart attack. Only 
one late infection was observed at 12 months in a 
patient treated for obstructive arterial disease. This was 
due to decubitus ulcer of the skin over the externally 
supported ePTFE graft. Cultures were negative and 
on Gram's stain only white blood cells appeared. 
Conservative treatment was instituted and both ulcer 
and graft healed with no recurrence after 2 years. 
Discussion 
The commonly accepted indications for extra-anatomic 
arterial reconstruction i the aortofemoral rea are 
either the poor general conditions of the patient or 
local conditions uch as multiple abdominal surgical 
procedures, or an infection, particularly an infected 
aortic graft. 4 We have also used a third indication, 
which is the presence of poor runoff smainly identified 
by severe disease of the profunda femoris and its 
branches, poor collateral circulation to the vessels 
below the knee and/or occlusion of the popliteal artery. 
Under those circumstances a small calibre prosthesis 
should be used, choosing a graft material with the 
best possible chances to remain patent in spite of 
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Table 3. Incidence of infection in extra-anatomic grafts used 
to treat infected aortic grafts compared to those implanted for 
obstructive aortofemoral disease*. 
Treatment ofinfected aortic graft 11 
10 ePTFE Infected 4 
--*5 (45%) 
1 Dacron Infected 1 
Five early infections --+ four unfavourable outcomes (1death) 
Treatment ofaortofemoral obstructive disease 82 
69 ePTFE Infected 3 
~3 (3.6%) 
13 Dacron None infected 
Two early ÷ one late infections ~ three favourable outcomes 
* Only ePTFE and Dacron grafts are considered since infection was 
not observed in other graft materials. 
a low flow, i.e. vein as first choice with ePTFE or 
homologous vein second. 
In our series 43 patients (20.2%) received an extra- 
anatomic procedure for the sole reason of poor runoff; 
however, 42 out of 154 classified as having "poor 
general condition" also had a poor runoff, taking 
the total number of cases with such an unfavourable 
haemodynamic condition to 85 (39.9%). This explains 
the large use of entirely venous grafts in our series 
(Table 1), not only for cross-femoral but occasionally 
also for axillofemoral bypasses, and of composite grafts 
with an axillofemoral ePTFE or Dacron segment and 
a venous cross-over to the side with the worse runoff. 
This possibly explains a good long-term patency of 
66% over a mean follow-up of 5 years, and also why 
the incidence of extra-anatomic graft infection in our 
cases is low, with the exception of those used in the 
treatment of infected aortic grafts. No infection was 
observed in autogenous or homologous vein and in 
composite grafts. The eight infected grafts were all 
prosthetic. There is some evidence that ePTFE is less 
prone to infection than Dacron, 6 although antibiotic 
impregnated Dacron tubes seem somewhat better. 7 The 
striking difference was that between extra-anatomic 
prosthesis used to treat an infected aortic graft and 
those implanted to treat aortofemoral obstructive dis- 
ease. Table 3 compares all ePTFE and Dacron grafts. 
They are divided according to the indication for their 
use: while four out of 10 ePTFE grafts used on an 
infected aortic graft became infected themselves, only 
three out of 69 implanted for obstructive arterial dis- 
ease were affected. The same observation was true for 
Dacron. Overall the infection rate was 45% for the first 
group and 3.6% for the second group. Furthermore, 
the difference in the final results should be noticed: 
four unfavourable outcomes for five graft infections 
in the first group versus three favourable outcomes in 
the second group. Certainly the nature of the infecting 
micro-organism plays a crucial role, but it should also 
be considered that at the present time aortic grafts 
infected by low virulence agents are now more often 
treated by in situ replacement s changing the indications 
for an extra-anatomic bypass. When the infecting agent 
is of high virulence and a staged procedure is planned 
for a revascularisation through an axil lofemoral/pop- 
liteal bypass and excision of an infected aortic graft, 
then the time interval might be sufficient to allow 
spreading of the sepsis to the new prosthesis. 
Conclusions 
Extra-anatomic grafts implanted to treat aortofemoral 
obstructive disease infection have a low frequency 
of infection which is relatively benign. Conservative 
treatment or partial excision with limb salvage is often 
possible. We believe that the extensive use of venous 
tissue significantly reduced the incidence of infection 
in extra-anatomic grafts. Conversely, infection is fre- 
quent in extra-anatomic grafts used to treat infected 
aortofemoral grafts due to highly virulent organisms, 
and the outcome was generally unfavourable. In such 
cases earlier detection of the aortic graft infection and 
staged procedures in rapid sequence might be the 
answer to this difficult problem. In extreme cases a 
one stage radical procedure (extra-anatomic bypass 
plus aortic graft excision) should still be considered. 
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